Citation Impact
Citing Papers
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
The endocannabinoid nervous system
2001
1',1'-Dimethylheptyl-delta-8-tetrahydrocannabinol-11-oic acid: a novel, orally effective cannabinoid with analgesic and anti-inflammatory properties.
1999
Actions of Cannabinoids on Membrane Properties and Synaptic Transmission in Rat Periaqueductal Gray Neurons In Vitro
2000
Cannabinoid-Induced Hypotension and Bradycardia in Rats Is Mediated by CB1-Like Cannabinoid Receptors
1997
Involvement of Dynorphin B in the Antinociceptive Effects of the Cannabinoid CP55,940 in the Spinal Cord
1997
Differential Blockade of the Antinociceptive Effects of Centrally Administered Cannabinoids by SR141716A
1998
Cannabinoid Transmission and Pain Perception
1998
Assessment of Anandamide Interaction with the Cannabinoid Brain Receptor: SR 141716A Antagonism Studies in Mice and Autoradiographic Analysis of Receptor Binding in Rat Brain
1998
Arachidonylethanolamide Induces Apoptosis of Human Glioma Cells through Vanilloid Receptor-1
2004
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
2002 Standout
Investigation of Structural Analogs of Prostaglandin Amides for Binding to and Activation of CB1 and CB2 Cannabinoid Receptors in Rat Brain and Human Tonsils
1999
Modulation of anxiety through blockade of anandamide hydrolysis
2002 Standout
Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes
1995 Nature
Cannabinoid CB1 Receptor Expression in Rat Spinal Cord
2000
Spinal cannabinoids are anti-allodynic in rats with persistent inflammation
1999
Brain Cannabinoid Systems as Targets for the Therapy of Neurological Disorders
1998
Pharmacological Activity of Fatty Acid Amides Is Regulated, but Not Mediated, by Fatty Acid Amide Hydrolase in Vivo
2002
The Subjective Psychoactive Effects of Oral Dronabinol Studied in a Randomized, Controlled Crossover Clinical Trial for Pain
2013
Anandamide Amidohydrolase Activity in Rat Brain Microsomes
1995
Cannabinoid receptor genes
1996
Descending control of pain
2002 Standout
Effects of AM281, a cannabinoid antagonist, on systemic haemodynamics, internal carotid artery blood flow and mortality in septic shock in rats
2005
Control of pain initiation by endogenous cannabinoids
1998 StandoutNature
The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain
2001
Potentiation of Δ9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of μ- and κ-opioid receptors
1996
The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat
2003
Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Δ9-THC and anandamide1Published on the World Wide Web on 18 January 2000.1
2000
Time course of the enhancement and restoration of the analgesic efficacy of codeine and morphine by Δ9-tetrahydrocannabinol
2006
The cannabinoid agonists WIN 55,212-2 and CP 55,940 attenuate rotational behavior induced by a dopamine D1 but not a D2 agonist in rats with unilateral lesions of the nigrostriatal pathway
1995
Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners
2004 Standout
The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons
1995
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
1999 StandoutNatureNobel
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
1996 StandoutNature
Molecular Neurobiology of The Cannabinoid Receptor
1996
Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A−/−, 5-HT1B−/−, 5-HT2A−/−, 5-HT3A−/− and 5-HTT−/− knock-out male mice
2007 StandoutNobel
Anandamide – the other side of the coin
2000 StandoutNobel
Pharmacological and biochemical interactions between opioids and cannabinoids
1999
Aversive effects of the synthetic cannabinoid CP 55,940 in rats
1996
Discovery and characterization of endogenous cannabinoids
1999
Locomotor networks are targets of modulation by sensory transient receptor potential vanilloid 1 and transient receptor potential melastatin 8 channels
2009 StandoutNobel
Cannabinoid Transmission and Reward-Related Events
1998
Effects of dietary 1,4-phenylenbis(methylene)selenocyanate on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA adduct formation in lung and liver of A/J mice and F344 rats
1996
The anandamide transport inhibitor AM404 activates vanilloid receptors
2000 StandoutNobel
Effects of SR 141716A after acute or chronic cannabinoid administration in dogs
1998
The adolescent brain and age-related behavioral manifestations
2000 Standout
The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain
1998
Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors
2004
Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system
2001
Characterization of a Novel Endocannabinoid, Virodhamine, with Antagonist Activity at the CB1 Receptor
2002
Activation of spinal cannabinoid 1 receptors inhibits C‐fibre driven hyperexcitable neuronal responses and increases [35S]GTPγS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats
2000
Inhibition of leukocyte function and interleukin-2 gene expression by 2-methylarachidonyl-(2′-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide
2005
Partial Purification and Characterization of the Porcine Brain Enzyme Hydrolyzing and Synthesizing Anandamide
1995
Cannabinoid (CB1) Receptor Activation Inhibits Trigeminovascular Neurons
2006
The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat
2004
Cerebrodiene, arachidonylethanolamide, and hybrid structures: potential for interaction with brain cannabinoid receptors
1996
Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance
2002
Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia
2005
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
A second endogenous cannabinoid that modulates long-term potentiation
1997 Nature
Discriminative stimulus effects of anandamide in rats
1995
Cannabinoid Control of Motor Function at the Basal Ganglia
2005
Unsaturated Long-Chain N-Acyl-vanillyl-amides (N-AVAMs): Vanilloid Receptor Ligands That Inhibit Anandamide-Facilitated Transport and Bind to CB1 Cannabinoid Receptors
1999 StandoutNobel
Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling
2013 StandoutNobel
Occurrence and postmortem generation of anandamide and other long‐chain N‐acylethanolamines in mammalian brain
1995
Simultaneous expression of human CYP3A7 and N-acetyltransferase in Chinese hamster CHL cells results in high cytotoxicity for carcinogenic heterocyclic amines
1995
Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen
2000
Evaluation of Cannabimimetic Discriminative Stimulus Effects of Anandamide and Methylated Fluoroanandamide in Rhesus Monkeys
1997
Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function
1995
Stereochemical Selectivity of Methanandamides for the CB1 and CB2 Cannabinoid Receptors and Their Metabolic Stability
2001
‘Endocannabinoids’ and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance
1998
Pharmacology of Cannabinoid Receptors
1995
Structure-activity relationships of anandamide, an endogenous cannabinoid ligand
1999
Δ9-Tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance
1998
Characterization of Δ9-Tetrahydrocannabinol and Anandamide Antinociception in Nonarthritic and Arthritic Rats
1998
Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase
2000
Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models
2005
Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat
1996
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide
1995
Arachidonylethanolamide (AEA) activation of FOS proto-oncogene protein immunoreactivity in the rat brain
1998
Positional Specificity of Rabbit CYP4B1 for ω-Hydroxylation1of Short-Medium Chain Fatty Acids and Hydrocarbons
1998
The endogenous cannabinoid system and its role in nociceptive behavior
2004
Cannabinoid receptors and pain
2001
Δ-9-Tetrahydrocannabinol increases prodynorphin and proenkephalin gene expression in the spinal cord of the rat
1997
Role of the Endogenous Cannabinoid System in the Regulation of Motor Activity
1998
Anandamide induces apoptosis of PC‐12 cells: involvement of superoxide and caspase‐3
2000
Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide
2000
The endogenous cannabinoid system and the basal ganglia
2002
Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB2 cannabinoid, as potential ligands for the cannabinoid receptors
1999
Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55,212-2
1998
Levels, Metabolism, and Pharmacological Activity of Anandamide in CB1 Cannabinoid Receptor Knockout Mice
2000
Pulmonary actions of anandamide, an endogenous cannabinoid receptor agonist, in guinea pigs
1998
AIN-93 Purified Diets for Laboratory Rodents: Final Report of the American Institute of Nutrition Ad Hoc Writing Committee on the Reformulation of the AIN-76A Rodent Diet
1993 Standout
Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock
1997 Nature
Cannabinoid antagonist AM 281 reduces mortality rate and neurologic dysfunction after cecal ligation and puncture in rats
2005
Ontogenetic development of the response to anandamide and Δ9-tetrahydrocannabinol in mice
1996
Progress and problems with the use of viral vectors for gene therapy
2003 Standout
Suppression of noxious stimulus-evoked expression of fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist
1996
Cannabinoids: a real prospect for pain relief
2002
G‐protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal
2004 StandoutNobel
Paresis Acquired in the Intensive Care Unit<SUBTITLE>A Prospective Multicenter Study</SUBTITLE>
2002 Standout
Transacylase‐Mediated and Phosphodiesterase‐Mediated Synthesis ofN‐Arachidonoylethanolamine, an Endogenous Cannabinoid‐Receptor Ligand, in Rat Brain Microsomes
1996
Reduction of opioid dependence by the CB1 antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction
2001
Prodrug activation enzymes in cancer gene therapy
2000
Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors
1998
Antihyperalgesic effects of spinal cannabinoids
1998
Biochemistry of the Endogenous Ligands of Cannabinoid Receptors
1998
Importance of quantitative genetic variations in the etiology of hypertension
2000 StandoutNobel
Tobacco Smoke Carcinogens and Lung Cancer
1999 Standout
An examination of the central sites of action of cannabinoid-induced antinociception in the rat
1995
The molecular logic of endocannabinoid signalling
2003 Standout
Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease
2003
Gene Transfer with Synthetic Cationic Amphiphiles: Prospects for Gene Therapy
1994
THE ACTIVATION OF CANNABINOID RECEPTORS IN STRIATONIGRAL GABAERGIC NEURONS INHIBITED GABA UPTAKE
1997
Effects of topical anandamides on intraocular pressure in normotensive rabbits
1996
Endocannabinoids and related fatty acid derivatives in pain modulation
2002
Antinociceptive actions of cannabinoids following intraventricular administration in rats
1993
Cannabinoid receptors undergo axonal flow in sensory nerves
1999
Anandamide Is Able to Inhibit Trigeminal Neurons Using an in Vivo Model of Trigeminovascular-Mediated Nociception
2004
Small‐Molecule Lipid‐Bilayer Anion Transporters for Biological Applications
2013
Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems
2005
Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview
2002
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
1995 Standout
The effects of cannabinoids on the brain
1999
Transient Receptor Potential Cation Channels in Disease
2007 Standout
The P450 Superfamily: Update on New Sequences, Gene Mapping, and Recommended Nomenclature
1991
Endocannabinoid system and opioid addiction: Behavioural aspects
2005
Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception
1999
Molecular and cellular basis of cannabinoid and opioid interactions
2005
Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia
2004
Involvement of the opioid system in the anxiolytic-like effects induced by Δ9-tetrahydrocannabinol
2002
The Endogenous Cannabinoid Anandamide and Its Synthetic Analog R(+)-Methanandamide Are Intravenously Self-Administered by Squirrel Monkeys
2005
Cannabinoid actions on rat superficial medullary dorsal horn neurons in vitro
2001
Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord
1999
Differential regulation of MyoD and myogenin mRNA levels by nerve induced muscle activity
1991 StandoutNobel
Laboratory evolution of a soluble, self-sufficient, highly active alkane hydroxylase
2002 StandoutNobel
Increased cannabinoid CB1 receptor binding and activation of GTP‐binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP‐treated marmosets
2001
Neuropharmacology and therapeutic potential of cannabinoids
2000
Distinct Risk Factor Profiles for Human Papillomavirus Type 16–Positive and Human Papillomavirus Type 16–Negative Head and Neck Cancers
2008 Standout
Role of extracellular disulfide-bonded cysteines in the ligand binding function of the .beta.2-adrenergic receptor
1990 StandoutNobel
Synthesis and Characterization of Potent and Selective Agonists of the Neuronal Cannabinoid Receptor (CB1)
1999
Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition
1997 Science
CANNABINOID RECEPTORS AND THEIR ENDOGENOUS AGONISTS
1998
Cannabis: pharmacology and toxicology in animals and humans
1996
Unmasking effect of alamethicin on the (Na+,K+)-ATPase, beta-adrenergic receptor-coupled adenylate cyclase, and cAMP-dependent protein kinase activities of cardiac sarcolemmal vesicles.
1980
Cannabinoid and Kappa Opioid Receptors Reduce Potassium K Current via Activation of GsProteins in Cultured Hippocampal Neurons
2000
Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB 1 Receptor Knockout Mice
1999 StandoutScience
Occurrence and Biosynthesis of Endogenous Cannabinoid Precursor,N-Arachidonoyl Phosphatidylethanolamine, in Rat Brain
1997
Motivational Effects of Cannabinoids Are Mediated by μ-Opioid and κ-Opioid Receptors
2002
Properties of human foamy virus relevant to its development as a vector for gene therapy
1999
Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide.
1995
1′,1′-Dimethylheptyl-Δ-8-tetrahydrocannabinol-11-oic Acid: A Novel, Orally Effective Cannabinoid with Analgesic and Anti-inflammatory Properties
1999
Determination of silicon and aluminum in biological matrixes by inductively coupled plasma emission spectrometry
1980
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.
1995 Standout
Anandamide modulates sleep and memory in rats
1998
Intensely pleasurable responses to music correlate with activity in brain regions implicated in reward and emotion
2001 Standout
Structural Requirements for Binding of Anandamide-Type Compounds to the Brain Cannabinoid Receptor
1997
Multi-State Regulation of the Dihydrogen Phosphate Binding Affinity to a Light- and Heat-Responsive Bis-Urea Receptor
2014 StandoutNobel
Cyclodextrin Drug Carrier Systems
1998 Standout
Reversal of Dopamine D2Receptor Responses by an Anandamide Transport Inhibitor
2000
Brown Adipose Tissue: Function and Physiological Significance
2004 Standout
Inactivation of the β-adrenergic receptor in skeletal muscle by dithiols
1983
A FAAH-Regulated Class of N-Acyl Taurines That Activates TRP Ion Channels
2006 StandoutNobel
The cardiac beta-adrenergic receptor. Structural similarities of beta 1 and beta 2 receptor subtypes demonstrated by photoaffinity labeling.
1983 StandoutNobel
Molecular aspects of the trophic influence of nerve on muscle
1983
Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors
1999
Cannabinoid receptor agonists and antagonists
1998
Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha -particle irradiated to nonirradiated cells
2001 Standout
Suppression of Noxious Stimulus-Evoked Activity in the Ventral Posterolateral Nucleus of the Thalamus by a Cannabinoid Agonist: Correlation between Electrophysiological and Antinociceptive Effects
1996
Cannabinoid-Induced Presynaptic Inhibition of Glutamatergic EPSCs in Substantia Gelatinosa Neurons of the Rat Spinal Cord
2001
The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons.
1996
Alterations in the morphology of rabbit skeletal muscle plasma membrane during membrane isolation
1984
Increase in aqueous solubility, stability and in vitro corneal permeability of anandamide by hydroxypropyl-β-cyclodextrin
1996
STRUCTURE AND FUNCTION OF FATTY ACID AMIDE HYDROLASE
2005
Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice
2003
Novel Pyrazole Cannabinoids: Insights into CB1Receptor Recognition and Activation
2001
Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.
1997
A possible role for glucocorticoids in denervation atrophy
1981
Rab3B protein is required for long-term depression of hippocampal inhibitory synapses and for normal reversal learning
2011 StandoutNobel
Cannabinoid Receptor Agonists Inhibit Glutamatergic Synaptic Transmission in Rat Hippocampal Cultures
1996
Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons
1999 Standout
Cannabinoids for Medical Use
2015 Standout
Postnatal development of palmitate oxidation and mitochondrial enzyme activities in rat cardiac and skeletal muscle
1982
Ultrastructure of the calcium release channel of sarcoplasmic reticulum.
1988 StandoutNobel
Pain modulation by release of the endogenous cannabinoid anandamide
1999
Regio- and Enantioselective Alkane Hydroxylation with Engineered Cytochromes P450 BM-3
2003 StandoutNobel
Effect of norepinephrine on consumption of oxygen in perfused skeletal muscle from cold-exposed rats
1988
Mechanism of Oxidation Reactions Catalyzed by Cytochrome P450 Enzymes
2004 Standout
Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells
2002
NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory
2006 Standout
Organoselenium and Organotellurium Compounds: Toxicology and Pharmacology
2004 Standout
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
2001
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Creatine and Creatinine Metabolism
2000 Standout
Cardiovascular Effects of Anandamide in Anesthetized and Conscious Normotensive and Hypertensive Rats
1997
Multiple Functions of Endocannabinoid Signaling in the Brain
2012
Works of P.Blaise Smith being referenced
Thiourea toxicity in mouse C3H/10T12 cells expressing human flavin-dependent monooxygenase 3
2002
Spinal mechanisms ofΔ9-tetrahydrocannabinol-induced analgesia
1992
The antinociceptive effects of intrathecally administered cannabinoids are influenced by lipophilicity
1992
4-Ipomeanol and 2-aminoanthracene cytotoxicity in C3H/10T12 cells expressing rabbit cytochrome P450 4B1
1995
Retroviral mediated expression of human cytochrome P450 2A6 in C3H/10T1/2 cells confers transformability by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)
1993
Recombinant DNA approaches for the development of metabolic systems used in in vitro toxicology
1992
Characterization of the β-adrenergic receptor and adenylate cyclase in skeletal muscle plasma membranes
1978
The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.
1994
β-Adrenergic receptor-adenylate cyclase of denervated sarcolemmal membrane
1978
Nebulization effects with acid solutions in i.c.p. spectrometry
1976
The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord.
1996
Postnatal development of glycogen- and cyclic AMP-metabolizing enzymes in mammalian skeletal muscle
1980
Isolation and characterization of the surface membranes of fast and slow mammalian skeletal muscle
1977
Cationic liposomes (Lipofectin) mediate retroviral infection in the absence of specific receptors
1990
Development of denervation alterations in surface membranes of mammalian skeletal muscle
1977
Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice.
1994